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New interventions against infectious diseases require a detailed knowledge and understanding of 
pathogen-host  interactions  and  pathogeneses  at  the  molecular  level.  The  combination  of  the 
considerable advances in systems biology research with methods to explore the structural biology of 
molecules  is  poised  to  provide  new  insights  into  these  areas. Importantly,  exploring  three-
dimensional structures of proteins is central to understanding disease processes, and  establishing 
structure-function relationships assists in identification and assessment of new drug and vaccine 
targets. 
Frequently, the molecular arsenal deployed by invading pathogens, and in particular parasites, 
reveals a common theme whereby families of proteins with conserved three-dimensional folds play 
crucial roles in infectious processes, but individual members of such families show high levels of 
specialisation which is often achieved through grafting particular structural features onto the shared 
overall fold. Accordingly, the applicability of predictive methodologies based on the primary 
structure of proteins or genome annotations is limited, particularly when thorough knowledge of 
molecular level mechanisms is required. Such instances exemplify the need for experimental three-
dimensional structures provided by protein crystallography, which remain an essential component 
of this area of research.
In the present article, we review two examples of key protein families recently investigated in our 
laboratories, which could represent intervention targets in the metabolome or secretome of 
parasites.
Introduction
Infectious diseases caused by eukaryotic pathogens represent a major disease burden to humans 
world-wide. In the absence of effective preventative approaches and new intervention strategies, 
this burden is likely to increase further,[1, 2] compounded by food and water shortages, economic 
crises, wars and climate change, particularly in disadvantaged countries. In addition, there is 
evidence of increasing problems with resistance in pathogens against a broad range of 
chemotherapeutic agents, compromising the treatment of infectious diseases.[3] Moreover, in spite of 
major efforts, there are very few examples of success in developing new drugs and vaccines against 
eukaryotic pathogens,[4, 5] indicating that alternative methods are needed at a time of major advances 
in molecular and computer technologies. In our opinion, the  development  of  new  treatments 
requires a detailed understanding of pathogens, host interactions and the molecular processes of 
disease. For instance, knowledge of the three-dimensional structures of proteins with pivotal roles 
in  disease,  and  the  probing  of  their  underlying  biology  are  crucial  for  understanding  the 
pathogenesis. Through establishing the relevant structure-function relationships, one can elucidate 
how individual proteins function, so that new ways of disrupting relevant pathways can be found, in 
order to facilitate the identification of new drug and vaccine targets.
This review covers recent investigations of two groups of socio-economically important pathogens 
of  humans  or  other  animals, the  blood  fluke  (schistosome)  Schistosoma  mansoni,  as  well  as 
hookworms (Necator americanus  and Ancylostoma species). We provide an account of some key 
parasite proteins studied in our laboratories and their proposed roles in biological pathways, with a 
view  towards  assessing  their  suitability  as  intervention  targets.  Proteins  providing  structural 
integrity are another promising interference target, and have been investigated in schistosomes,[6] 
tape worms[7] as well as the protistan  Giardia intestinalis (Metamonada),[8] which is the cause of 
chronic diarrhoea in  animals.  Parasite  target  proteins  involved in  structural  integrity have been 
reviewed in detail elsewhere.[9, 10]
The technique of protein crystallography is poised to deliver much needed insights into the 
structure-function relationships of key pathogen molecules and their interactions with host proteins. 
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Combined with cell and immuno-biological investigation,[11, 12] next-generation sequencing and 
transcriptomics methodologies,[13] advanced modelling approaches[14] and the probing of key 
proteins with small molecules,[15] crystallography continues to provide the crucial information for 
rationale and target discovery. 
Members of the genus Schistosoma pathogenic flatworms are  responsible for chronic infections 
throughout Africa and many parts of the world. Schistosoma mansoni causes hepato-intestinal 
schistosomiasis due to the predilection of adult parasites to life in the mesenteric veins and its 
branches. Transition to parasitism in schistosomes involves major structural alterations of the apical 
membranes, and effective disruption of this layer might lead to death of these parasites within the 
host.
Hookworms are avid blood feeders. Adult hookworms inhabit the intestine of their hosts, where, by 
virtue of anatomic adaptations of their mouth-parts and strong secretory activity, they are able to 
imbibe quantities of their host blood. Prolonged infection with hookworms can give rise to severe 
sequelae associated with anaemia and can lead to developmental and cognitive impairment, 
particularly in children.
Proteins in metabolic pathways: saposin-like proteins
Saposin-like proteins (SAPLIPs) are a large and diverse family of proteins that interact with lipids. 
The proteins share little sequence homology amongst one another, but all have a conserved tertiary 
structure which defines the family. A subset of SAPLIPs, the mammalian saposins are activator 
proteins that facilitate degradation of glycosphingolipids and promote their hydrolytic processing by 
exohydrolases.[16] Despite their similar structure, each saposin targets a distinct sphingolipid and 
enables its degradation by a partially overlapping set of enzymes.[17] Saposins are further linked to 
the human immune response by loading hydrophobic lipid antigens from lysosomal membranes 
onto human CD1 molecules where they can be processed further by the immune system.[18] In 
accord with these activities, saposins possess membrane binding and lipid transport properties, and 
they destabilise phospholipid vesicles and modulate the membrane structure in a detergent-like 
manner.[19] 
SAPLIPs of blood flukes (or schistosomes) have attracted considerable interest, since they possess 
immunogenic properties;[20] transcriptomic analyses have revealed their presence in the parasite's 
gut[21, 22] and might thus be intimately linked to its ability to uptake nutrients.
Although the detailed mechanisms of SAPLIP-mediated enzyme activation are unknown, it is 
generally assumed that these proteins remodel the membrane by interacting with lipids; they are 
also able to interact directly with lipid degrading enzymes, thus providing a platform for lipid 
hydrolases.[23] SAPLIPs are crucial molecules for the survival of many organisms. For instance, 
SAPLIP-deficient Caenorhabditis elegans is overcome by bacteria in culture,[24] because the worm 
is unable to induce bacterial lysis. In humans, deficiencies in saposins A, B or C lead to Krabbe-like 
disease,[25] metachromatic leukodystropy[26] and Gaucher-like disease,[27] respectively.
SAPLIPs are also important contributors in host interactions. Amoebapores A-C are SAPLIPs and 
virulence factors of the agent of amoebic dysentery, Entamoeba histolytica, a protozoan parasite 
that kills host cells by forming pores in their lipid membranes.[28] In addition, SAPLIPs from the 
metazoan liver flukes Clonorchis sinensis (clonorin)[29] and Fasciola hepatica (Fh-SAP-2)[30] are 
haemolytic and are likely intimately involved in host responses. Thus, in addition to their diagnostic 
potential,[31, 32] they are immunogenic. For instance, a recombinant form of Fh-SAP-2 has achieved 
>80% protection against F. hepatica challenge infection in rabbits[30] and a reduction in worm 
burdens in mice when vaccinated with a cDNA construct of Fh-SAP-2.[33] This protection level 
compares with other vaccine targets for fascioliasis with efficacies of 40-74%.[34-36] Moreover, sera 
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from experimental mice infected with S. mansoni reacted to Fh-SLP-2 in vitro, thus showing cross-
reactivity[37] and suggesting that helminth SAPLIPs might be able to protect against trematodes 
more broadly.
Interestingly, a number of human Sap domain-containing proteins, including granulysin, NK-lysin 
and surfactant protein B, have activity against a range of targets, such as tumor cells, bacteria, fungi 
and parasites,[38-40] and, accordingly, are considered components of the innate (not antibody 
provided) immune system.
Despite the conservation of the Sap domain, the fold of individual SAPLIPs is adapted to carry out 
particular and diverse functions at biological membranes ranging from cytolytic properties of 
amoebapores,[28] granulysin[41] and NK-lysin[42] to plant aspartic proteases[43] and neurotrophic 
factors.[44] Due to the many variations and adaptations in protein families such as this, experimental 
three-dimensional structures of individual members are indispensable. 
Typical structural characteristics of the Sap domain include a jaw- like arrangement of  a four- or 
five-helix bundle where a kink in the third helix can lead to occurrence of two helices (see Figure 
1). Three conserved dithioether bonds link the helices within each lobe but not across the jaw.
Recently, we determined the crystal structures of two novel SAPLIPs (called Na-SLP-1 and Ac-
SLP-1) from human and dog hookworms Necator americanus and Ancylostoma caninum.[45] 
Despite the same numbering, these two proteins are not close orthologues –  a conclusion that is 
supported by insights gained into the molecular mechanisms of these proteins. Although the crystal 
structures of both Na-SLP-1 and Ac-SLP-1 suggest that these molecules form differing P2-
symmetric dimers, only Ac-SLP-1 exists as dimers in solution. Based on the observed three-
dimensional Ac-SLP-1 dimer, it  has  been  possible  to  suggest  a  likely membrane-associated 
mechanism (see below), which would not have been possible without knowledge obtained from the 
crystal structure.
A particular feature of many Sap domains is the loose packing of side chains in the core, where 
large void volumes result in an 'oily' and mobile core.[41] In the three-dimensional crystal structure 
of Na-SLP-1, at least a dozen void volumes (> 5 Å3) have been found, the largest one being 43 Å3. 
In contrast, Ac-SLP-1 presents itself as a well-ordered protein, from which void volumes are absent 
and, therefore, devoid of an 'oily' feature. 
The membrane-associated activities of Sap domain containing proteins appear to be quite varied 
(see Figure 2). The main characteristics identified to date are described in the following:
(1) Extensive protein-protein interactions have been observed in the crystal structure of human 
granulysin,[28] suggesting that a two-dimensional layer of granulysin covers the membrane surface, 
achieved by a roll-on mechanism. The lipid extraction activity has been proposed to occur via a 
scissor-like action of the two 'jaws'. In contrast to amoebapore A (see below), the membrane 
permeabilising species of granulysin and NK-lysin appear to be monomeric within a membrane-
infesting carpet. In this model, each monomer is bound to the membrane surface via a highly 
positively charged surface area, and the high density of positive charges on the SAPLIPs is assumed 
to cause membrane destabilisation by electroporation.[46]
Noteworthy is the observation that the crystal structure of Na-SLP-1 from human hookworm and 
the membrane binding data obtained for this protein[44] is similar to granulysin; however, neither 
haemolytic nor liposome destabilisation has been observed thus far for Na-SLP-1.
(2) For human saposins C and D, a mechanism has been proposed that comprises the annealing of 
dimeric species to the membrane via the amphipathic helices α2 and α3-4, respectively. This 
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generates conformations competent for lipid extraction[47] and enables the saposins to function as 
activators that deliver lipids to lipases which are unable to penetrate the membrane.
(3) A clip-on model has been suggested for membrane fusion events mediated by saposin C. Again, 
the occurrence of a saposin dimer species is required for this membrane-linked mechanism to 
proceed.[48]
(4) The crystal structure of Ac-SLP-1, a novel SAPLIP from the dog hookworm, reveals  a 
symmetrical dimer and a central, buried hydrophobic surface that mainly comprises the solvent-
exposed side of helix 3.[45] Supported by native gel and size exclusion chromatography data,[45] this 
dimer is believed to be the physiologically relevant species of molecule in solution. The dimer 
features a linear groove, lined with acidic residues on one side of the globular shape, connecting 
large cavities at the distal ends. Although the physiological role of these connected cavities is not 
yet known, its structural features are poised to shuttle molecules between the membrane surface and 
the hydrophilic medium beneath it. Intriguingly, the crystal structure shows a citrate and two 
HEPES molecules (from the crystallisation buffer) bound in the connecting groove. Since the Ac-
SLP-1 crystal structure does not display any obvious, privileged sites for membrane interactions, a 
membrane binding mechanism that involves disassembly of the dimer upon initial contact with the 
membrane surface and annealing of the hydrophobic side of helix 3 to the membrane seems 
plausible.
(5) The pore-forming amoebapore A from the parasitic amoeba E. histolytica has been shown in an 
NMR study to assemble into dimers in a pH-dependent fashion, mediated by the single histidine 
residue (His75) of this protein.[28] By means of molecular modelling, a trimer of dimers has been 
proposed that has a mainly hydrophobic outer torus surface, whereas the surface lining the putative 
pore shows mainly basic character. The modelled pore diameter of about 20 Å is in excellent 
agreement with its pore size estimated by electrophysiological means.[49]
(6) The crystal structure of saposin B revealed two dimers, a symmetric (crystallographic) dimer, 
and an asymmetric dimer with a large hydrophobic pocket of about 900 Å3 at the subunit interface 
that can harbour lipid molecules.[50] Based on these findings, it has been proposed that a 
conformational switch governing flexibility at the opening of the hydrophobic cavity facilitates the 
transition between the active and inactive form of this protein. When active, saposin B forms a 
complex with extracted lipid molecules that is recognisable by lipases and hence, facilitates 
membrane degradation.[50]  While the precise mode of saposin B membrane association has yet to be 
proposed, the use of a conformationally flexible dimer for lipid extraction suggests that the pathway 
may be similar to those of saposins C and D.
Excreted/secreted products: SCP/TAPS proteins
Owing to their life style, parasitic worms release a myriad of factors in order to regulate the 
immune response of the host.[51] The decoding of this secretome (= exported proteome) has 
experienced a recent boost with the deployment of modern genomic and transcriptomic 
sequencing[52] as well as proteomic analyses.[53] Since nematode secretomes are complex in 
composition, it is not a trivial task to identify biologically active components. Two main approaches 
are currently being applied: (i) a systematic analysis that attempts to identify secreted proteins that 
are conserved among inhabitants of a particular ecological niche (such as for example the 
gastrointestinal tract, bile duct, etc), and (ii) a pragmatic approach that identifies the most abundant 
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proteins secreted within the host environment.
The two approaches may not need to be exclusive. The activation-associated secreted proteins 
(ASPs) of hookworms, for example, are amongst the ten most abundant groups of proteins in 
hookworms,[54] and their transcription is highly up-regulated when the free-living parasite 
transforms to the parasitic stages.[55] ASPs belong to the family of sperm-coating protein (SCP)-like 
extracellular proteins, also called SCP/TAPS proteins, and as such are part of the cysteine-rich 
secretory protein (CRISP) superfamily. The involvement of SCP/TAPS proteins in fundamental 
biological processes in eukaryotes is undoubted, and there are prominent examples of highly 
bioactive molecules, such as the allergens from the venoms of fire ants (Sol i2, Sol i3), wasps (Ves 
V5), snakes (e.g. triflin) and others.[54] In S. mansoni, for example, members of this protein family 
are known as the Venom Allergen-Like proteins (Sm-VALs).
ASPs,[56] including Sm-VALs,[57] have received attention as targets for anti-parasite intervention, 
since they are expressed abundantly in the infective stages of the parasites and are also 
immunogenic. With the help of structural biology methodologies, we have recently embarked on 
systematic analyses of ASPs, and developed a framework of classification for these proteins using 
structure-based amino acid alignments[58, 59] and phylogeny,[54, 60-62] yielding (at least) three different 
groups.
Interestingly, ASPs often share low amino acid sequence identities among one another, but possess 
a conserved fold in the N-terminal PR (or CAP) domain, characterised by a central anti-parallel b-
sheet that is embraced by helical motifs (α-β-α sandwich), and several disulphide bonds that provide 
structural stability of this fold (see Figure 3). The fold of the C-terminal domain of SCP/TAPS 
proteins can vary, but in the case of hookworm ASPs, Hinge-like sequence of CRISPs with a 
conserved cystein pattern of C-X5-C-X7-C- X4-C[63] have been found.[59] The three-dimensional 
structures of representative members of Group 1 (Na-ASP-2[64]) and Group 2 (Ac-ASP-7[59]) ASPs 
confirm the significant structural differences between these groups, and crystallographic analyses 
have also revealed the presence of metal-binding sites that differ between the two groups. For 
Group 1 ASPs, one of the prominent structural features is an equatorial groove that extends 
approximately around half of the molecule and harbours a tandem histidine motif (His88 and 
His148 in Na-ASP-2) which has the ability to bind a variety of transition metals.[65] In Group 2 
ASPs, this structural feature is absent.
That ASPs are secreted proteins suggests particular roles at the parasite-host interface, including: (i) 
decoy molecules to divert the immunological response by the host; (ii) modulation/suppression of 
the immunological response by interaction with relevant host receptors; and (iii) protection of the 
parasite by removal of undesired chemical entities. Hypothetically, using the metal binding sites 
observed in Group 1 and Group 2 ASPs,[59, 65] these proteins could act as catcher molecules for 
undesired metal ions that might be damaging to the parasite.
However, the presence of the equatorial groove on Group 1 ASPs stimulated the hypothesis that 
peptides might be bound in this location.[59] By screening peptide libraries by phage panning, a 
peptide sequence has recently been identified that specifically binds to Na-ASP-2 and shows high 
identity to a peptide of the extracellular domain of the human SK3 channel.[64] Direct interactions 
between an SK3 peptide and Na-ASP-2 could be confirmed by modelling and thermostability 
experiments.[65] 
Although ion channels are best known for their roles in neuronal and cardiac action potentials, their 
importance in immune cells is less well characterised. Recent reports indicate that SK channels play 
a role in mediating reactive oxygen species (ROS) production.[66] Putatively, ASPs may act 
similarly to the bee venom apamin and block the production of ROS[66] that are toxic to invading 
hookworm larvae as they migrate through host tissues to the gastrointestinal tract.
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To date, there is only one hookworm ASPs for which a molecular biological function has been 
experimentally confirmed. Neutrophil inhibitory factor (Ac-NIF) is a Group 1 ASP from A. 
caninum and modulates the immune response by inhibiting neutrophil recruitment by direct 
interaction with complement receptor 3.[67] Intriguingly, Ac-NIF has recently been shown in a mouse 
model to inhibit early stages of diabetic retinopathy without compromising the immune 
surveillance.[68] Less is known for another A. caninum ASP termed hookworm platelet inhibitor 
(HPI), which acts as an antagonistic ligand of cell surface integrins (IIbb3 and 2b1), resulting in the 
inhibition of the aggregation and adhesion of platelets.[69]
To date, the interaction of Ac-NIF with complement receptor 3 constitutes the only experimentally 
proven interaction of an ASP with a human receptor. As a member of the complement system, 
complement receptor 3 (a heterodimeric complex consisting of M- and b2-integrin) is a cell surface 
receptor on human leukocytes and macrophages that constitutes the innate immune system and 
helps to clear pathogens. Integrins consist of a family of proteins that form heterodimers with one  
and one b chain. These heterodimers are the major adhesion receptors and mediate essential cellular 
functions. They play a role in cell-cell interaction, development, immune responses, leukocyte 
traffic and are at the heart of many diseases including cancer.[70] The human genome comprise of 18 
 subunits and 8 b subunits that assemble into 24 distinct integrins with specific, non-redundant 
function. Whereas b2-integrins have been implicated in the recognition and binding of molecules 
originating from bacterial and yeast pathogens, viruses appear to use mainly b3-integrins (and to a 
lesser extent b1, b5 or b7-integrins) for cell entry.[71] Intriguingly, Ac-NIF appears to specifically bind 
to the  subunit of complement receptor 3[72] and localise to the I-domain of M[73] that contains the 
metal ion-dependent adhesion site (MIDAS).[74] In terms of structural elucidation, the molecular 
interactions between viruses or viral proteins with integrins have been investigated in many 
instances, and include three-dimensional structures by electron microscopy or crystallography.[71] 
Surprisingly, the investigation of parasite interactions with integrins is much less advanced (see 
Table 1).
Future directions
Saposin-like proteins
As  potentially  membrane-lytic  proteins,  SAPLIPs  are  likely  to  play  key  roles  in  schistosome 
metabolism;  they  are  abundant,  with  14  Sap-domain  proteins  known for  S.  japonicum.[22] The 
molecules are also highly conserved across the three main species of Schistosoma  (S. mansoni, S. 
japonicum and S. haematobium) which cause the majority of cases of schistosomaisis in humans, 
yet they share little amino  acid  sequence  identity  to the saposins from the human host. This 
information indicates that this group of molecules will be interesting to explore biologically in 
schistosomes and other blood-feeding helminths and that they have potential as targets of parasite 
intervention. The genomes of all three human schistosomes have been sequenced, and all three 
trematodes can be maintained in the laboratory in rodents and snails. Both larval and adult worms 
of schistosomes can be maintained in culture in vitro and are amenable to RNA interference 
(RNAi).[72] In contrast to a number of other parasites, where  RNAi  has  not  been  reported  or 
inconsistent susceptibilities have been observed,[73] schistosomes, particularly S. mansoni, should 
allow integrated studies of SAPLIPs, combining functional explorations with elucidation of these 
proteins  at  the  molecular,  structural  and/or  immuno-biochemical  levels.  Conclusions regarding 
homologous structure-function relationships, from one individual SAPLIP to another, are not 
advisable for the reasons discussed in this review. However, there is an anticipation that comparison 
of SAPLIP family  members,  and  particularly  orthologous  proteins,  across different nematode 
species – after phylogenies have been established – should allow conclusions to be made regarding 
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shared SAPLIP mechanisms among species. Ultimately, this might provide a basis for the definition 
of intervention targets and, subsequently, the design of treatments with relatively broad 
applicability.
SCP/TAPS proteins
Although SCP/TAPS proteins (including ASPs) appear to be central to the interplay between 
parasite and host, there are very scarce data about the identity of the host targets and very little 
structural information that could provide clues about molecular mechanisms, thus impacting on the 
opportunities for rational/structure-guided discovery of novel interventions.
An understanding of the involvement of structural motifs of integrins in this context is just 
beginning to emerge. On the one hand, host integrins might be attacked by proteins secreted by 
parasite, to interfere with signalling and promotion of cell-cell/cell-ECM contacts, ultimately 
modulating immune responses. Interestingly, integrin-like structural features have been observed in 
parasite surface proteins (e.g. TRAPs) and may thus provide pathways of parasite entry by forming 
multivalent adhesive junctions. Information about three-dimensional structures of such interactions 
are thus in high demand, particularly because comparative modelling may not allow the 
extrapolation of findings obtained from “prototype” complexes, as subtle differences even among 
members of the same protein fold can lead to different interactions. Mechanisms of conformational 
regulation, such as subtle differences in the metal coordination of the metal ion-dependent adhesion 
site (MIDAS) of b2-integrin regulating integrin function[77] makes the requirement for atomic 
details of the particular complexes even more important.
Integrins are known targets of therapeutic drugs against thrombosis and  inflammation[78] and thus 
might have potential as drug targets in parasites. We anticipate that future crystal structure studies 
of integrin-ASP complexes will lead to discoveries that can assist the development of novel 
therapeutic approaches for infectious and inflammatory diseases.
Conclusions
As  with  many other areas of the life sciences, structural biological investigations by X-ray 
crystallography have contributed immensely to our understanding of pathogen-host interactions. 
The genomic and transcriptomic data that are increasingly becoming available from parasitic 
organisms provide an unprecedented resource for targeted investigation of parasite-host protein 
complexes. Such crystal structures are in high demand, as the molecular armory of parasites is 
manifold, and comparative modelling will not be able to account for the significant differences in 
the structure-function relationships. The protein families, saposin-like proteins and SCP/TAPS 
proteins, highlighted in this review are key examples in this context, since both families are 
characterised by highly conserved three-dimensional folds, but structure-function relationships can 
substantially differ among the individual members, owing to the low amino acid sequence identity 
between or among them. Protein crystallography will thus remain an integral part in establishing the 
molecular mechanisms of infectious diseases as well as the development of novel interventions in 
this area.
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Table 1
A non-exhaustive survey of molecular parasite-host interactions employing cell surface receptors
Parasite protein Functional role Host receptor Comments Reference
Entamoeba histolytica
37 kDa surface protein Unknown Fibronectin Identity of the membrane-associated parasite protein remains unknown. [79]
140 kDa surface protein Unknown Fibronectin Parasite protein shows functional similarities to b1 integrin. [80]
Pyrenophora triticirepentis
ToxA Secreted integrin 
antagonist with RGD 
motif
Plant integrin-
like receptors
ToxA is plant pathogen of fungal origin with known crystal structure 
(PDB accession codes: 1zld, 1ale).
[81]
Toxoplasma gondii, Plasmodium
TRAP Hepatocyte invasion Sulfogalactosy
l-cerebrosides 
(sulfatides),
b2-integrin, 
Heparin?,
SH3-domain 
containing 
proteins
TRAP proteins possess multiple adhesion domains, including an A-
domain as well as a type 1 thrombospondin-like repeat (TSP-1).
Structures of the human thrombospondin-1 type 1 repeats (PDB 
accession code 1lsl) and the TSR domain of a Plasmodium TRAP (2bbx) 
are known.
[82-85]
Ancylostoma ceylanicum
Ace-MIF Cytokine ortholog CD74 The macrophage migration inhibiting factor (MIF) acts as a lymphocyte 
chemo-attractant, similar to the human orthologue and possesses 
tautomerase activity. Vaccination provided partial protection from 
disease. Crystal structures of the protein in the apo (PDB accession code: 
2os5) and drug-bound states are known (3rf4, 3rf5).
[86, 87]
Ancylostoma caninum
NIF Integrin antagonist Complement Interaction with complement receptor 3 and inhibition of neutrophil [67, 68]
receptor 3 
(Mb2-
integrin)
recruitment. Beneficial effect in early diabetic retinopathy.
HPI Integrin antagonist IIbb3 integrin, 
2b1 integrin
Blocks platelet aggregation and adhesion. [68]
Necator americanus
Na-ASP-2 Unknown SK3 channel?
CD79A?
A vaccine candidate that suffers from IgE-mediated allergic reactions in 
humans. Crystal structures of apo and metal-bound Na-ASP-2 are known 
(PDB accession codes: 1u534, 4nui, 4nuk, 4nun, 4nuo). 
[65, 88, 89]
Leishmania
Parasite surface antigen 
2 (PSA-2)
Complement 
receptor 3 
(Mb2-
integrin)
Strong indications that the LRR domain binds the CR3 and contributes to 
invasion.
[90]
Lipophosphoglycan Complement 
receptor 3 
(Mb2-
integrin)
Direct interactions with lipopolysaccharide-binding site of CR3; opsoni-
sation of  C3b and iC3b.
[91]
Schistosoma mansoni
23 kDa secreted protein Host cell apoptosis Death 
receptors
Host cell apoptosis is a common strategy among parasites, including 
schistosomes, N. americanus, F. hepatica, Paragonimus westermani, 
Taenia crassiceps, Trypanosoma cruzi, Leishmania donovani, and 
Cryptosporidium parvum.
[92]
Integrin-like cell 
surface receptors
Modulation of host 
phagocytosis and 
chemotaxis
CD15 Parasite CR3-like proteins cause antibody-dependent cell-mediated 
cytotoxicity (ADCC) of macrophages.
[93]
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Figure Legends
Figure 1
Crystal structures of Na-SLP-1 (PDB accession code 3s63) and Ac-SLP-1 (PDB accession code 
3s64). The topology of the Sap domain fold is highlighted by the blue/orange colouring. Disulphide 
linkages are rendered as stick models and coloured yellow. Both structures reveal dimeric 
arrangements with interface areas of 571 Å2 and 767Å2, respectively. As suggested by the rather 
small interface area observed in the Na-SLP-1 crystal structure, this protein exists exclusively as 
monomer in solution. Ac-SLP-1, in contrast, is dimeric in solution.  The dimer interface of Ac-SLP-
1 features a long groove in which a citrate and two HEPES molecules were found in P2-symmetric 
positions. The citrate molecule occupies a special position and only one conformation is shown for 
clarity. Protein structures were rendered with PyMOL.[94]
Figure 2
Versatile membrane interactions by Sap domain-containing proteins. Saposins and SAPLIPs 
employ various mechanisms for membrane binding, solubilisation, and fusion. Whereas binding 
primarily occurs through direct hydrophobic contacts, in some cases, it is facilitated or preceded by 
electrostatic targeting driven by positively charged residues which position the protein at the 
membrane surface. This is followed by rotation or conformational changes to expose hydrophobic 
interfaces for binding. For literature references, please see the main text.
For granulysin (PDB accession code 1l9l), Na-SLP-1 (3s63), saposins C (2qyp) and D (3bpq) and 
Ac-SLP-1 (3s64), the N- and C-terminal helices (α1 and α5) are coloured blue, and helices α2 - α4 
are orange. For the oligomeric species of saposin B (1n69) and amoebapore A (1fo9), these colours 
indicate different monomers. The proposed membrane-inserting amoebapore A hexamer is also 
rendered as surface representation with a colour ramp where red indicates high hydrophobicity. 
Protein structures were rendered with PyMOL.[94]
Figure 3
Comparison of Group 1 and Group 2 ASP structures, exemplified by Na-ASP-2 (PDB accession 
code 4nui) and Ac-ASP-7 (PDB accession code 3s6v). The N-terminal PR (CAP) domain is 
coloured blue, the C-terminal Hinge-like domain is rendered in red. Cysteine residues and 
disulphide bonds are shown as stick models in yellow. Group 1 ASPs (left) possess an equatorial 
groove that features a prominent tandem-histidine motif capable of binding metals (shown here is 
coordination of a Co2+ ion by His 88 and His148 and four water molecules). This groove is absent 
from Group 2 ASPs (right) due to absence of a linker of ~25 amino acids length between the two -
helices on the left hand side, which also results in absence of a disulphide bond. The Hinge-like 
domain of Ac-ASP-7 can bind a variety of metal ions; shown here is a Mn2+ ion. Protein structures 
were rendered with PyMOL.[94]
16
Mason et al. Structures of parasite proteins
Figures
Figure 1
Crystal structures of Na-SLP-1 (PDB accession code 3s63) and Ac-SLP-1 (PDB accession code 
3s64). The topology of the Sap domain fold is highlighted by the blue/orange colouring. Disulphide 
linkages are rendered as stick models and coloured yellow. Both structures reveal dimeric 
arrangements with interface areas of 571 Å2 and 767Å2, respectively. As suggested by the rather 
small interface area observed in the Na-SLP-1 crystal structure, this protein exists exclusively as 
monomer in solution. Ac-SLP-1, in contrast, is dimeric in solution.  The dimer interface of Ac-SLP-
1 features a long groove in which a citrate and two HEPES molecules were found in P2-symmetric 
positions. The citrate molecule occupies a special position and only one conformation is shown for 
clarity. Protein structures were rendered with PyMOL.[94]
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Figure 2
Versatile membrane interactions by Sap domain-containing proteins. Saposins and SAPLIPs 
employ various mechanisms for membrane binding, solubilisation, and fusion. Whereas binding 
primarily occurs through direct hydrophobic contacts, in some cases, it is facilitated or preceded by 
electrostatic targeting driven by positively charged residues which position the protein at the 
membrane surface. This is followed by rotation or conformational changes to expose hydrophobic 
interfaces for binding. For literature references, please see the main text.
For granulysin (PDB accession code 1l9l), Na-SLP-1 (3s63), saposins C (2qyp) and D (3bpq) and 
Ac-SLP-1 (3s64), the N- and C-terminal helices (α1 and α5) are coloured blue, and helices α2 - α4 
are orange. For the oligomeric species of saposin B (1n69) and amoebapore A (1fo9), these colours 
indicate different monomers. The proposed membrane-inserting amoebapore A hexamer is also 
rendered as surface representation with a colour ramp where red indicates high hydrophobicity. 
Protein structures were rendered with PyMOL.[94]
18
Mason et al. Structures of parasite proteins
Figure 3
Comparison of Group 1 and Group 2 ASP structures, exemplified by Na-ASP-2 (PDB accession 
code 4nui) and Ac-ASP-7 (PDB accession code 3s6v). The N-terminal PR (CAP) domain is 
coloured blue, the C-terminal Hinge-like domain is rendered in red. Cysteine residues and 
disulphide bonds are shown as stick models in yellow. Group 1 ASPs (left) possess an equatorial 
groove that features a prominent tandem-histidine motif capable of binding metals (shown here is 
coordination of a Co2+ ion by His88 and His148 and four water molecules). This groove is absent 
from Group 2 ASPs (right) due to absence of a linker of ~25 amino acids length between the two -
helices on the left hand side, which also results in absence of a disulphide bond. The Hinge-like 
domain of Ac-ASP-7 can bind a variety of metal ions; shown here is a Mn2+ ion. Protein structures 
were rendered with PyMOL.[94]
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